Conclusion: Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.
PubMed 30097390 ↗Clonidine
The short answer. More people than not who report on Clonidine say it helped (63% of 30). It is most often used for anxiety: 100% of 17 reports say that improved. It is well studied — 311 meta-analyses on PubMed. The most common complaint is drowsiness.
From 72 mentions in total — the rest didn't say how it went and aren't counted.
What Clonidine does, according to users
Of the people who reported each effect, the share who said it got better.
6 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 311 meta-analyses on PubMed ↗ · 1,394 randomized trials ↗
Conclusion: Good support was provided in the 11 studies for the use of adjunctive family-focused psychotherapeutic approaches, and this approach should be considered an important part of any treatment regimen. The pharmacological treatment landscape for S-USBD lacks a systematic research base, warranting further exploration with controlled clinical trials. Case series indicate promising treatment outcomes for TSDD with high-dose lithium, clonidine, ketamine, and other cooling measures. Validation of this novel treatment strategy in controlled trials is needed to advance the management of the S-USBD varian
PubMed 40844121 ↗Conclusion: All investigated nonstimulants were more efficacious in the treatment of ADHD in adults, than placebo, while the placebo had better acceptability and tolerability.
PubMed 37166701 ↗Conclusion: ketamine and i.v. dexmedetomidine.
PubMed 39129451 ↗332 human trials on ClinicalTrials.gov test Clonidine — 192 completed, 24 recruiting now. See all on ClinicalTrials.gov ↗
- Regional Anesthesia EMG Study · Surgery · 2025
- Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream · Peripheral Arterial Occlusive Disease · 2016
- Epidural Analgesia for Pancreatitis (Epipan Study) · Severe Acute Pancreatitis · 2019
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “The 500 mcg/mL strength product should be diluted prior to use in an appropriate solution. NOTE: Clonidine hydrochloride injection (epidural clonidine) is not recommended for obstetrical, post-partum, or peri-operative pain management. The risk of hemodynamic instability, especially hypotension…”
27 recalls of products named for Clonidine. Most recent:
- 2026-04-15 · Class II: CGMP Deviations: use of an unapproved raw material record ↗
- 2022-09-28 · Class III: Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets, record ↗
- 2022-06-29 · Class II: Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
55,961 adverse-event reports mention Clonidine. Most often reported:
- Drug ineffective · 4,333
- Pain · 3,490
- Fatigue · 3,482
- Nausea · 3,439
- Off label use · 3,427
- Headache · 3,372
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Clonidine E — an unlikely cause of liver injury. LiverTox entry ↗
NIH has funded 43 research projects with Clonidine in the title, $10,788,605 in total (1985–2011). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Clonidine ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Clonidine really helped me when I was getting off benzos. I still use it now as a replacement for when I get anxiety.”
“it made me feel dizzy, sleepy, cognitively much worse during the day...felt like the two medications were fighting for supremacy.”
“For acute anxiety or panic attacks I take Clonidine at 100mcg. It also makes an excellent sleeping pill.”
“I get some sleep now with .1mg clonidine and 25 mg atarax combined but it's often short and really broken up.”
Top discussions (5)
- Sulforaphane is doing wonders for my ADHD.. Finally some relief ↗
- Guanfacine vs clonidine vs modafinil vs adderall ↗
- GH upregulates GABA B Receptors, Stimulates neurogenesis ↗
- ADHD medication isn't helping with executive dysfunction, what now? ↗
- Gaboxadol—the almost-too-good-to-be-true hypnotic, and why we can't have nice things. ↗
Clonidine compared
Other options for anxiety
Sources
- User reports: 72 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate